M 106 (Zidovudine 300 mg)

Pill with imprint M 106 is White, Round and has been identified as Zidovudine 300 mg. It is supplied by Mylan Pharmaceuticals Inc..

Zidovudine is used in the treatment of hiv infection; occupational exposure; reduction of perinatal transmission of hiv; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Zidovudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 106

Zidovudine

Imprint: M 106
Strength: 300 mg
Color: White
Size: 10.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Nucleoside reverse transcriptase inhibitors (nrtis)
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Mylan Pharmaceuticals Inc.
National Drug Code (NDC): 00378-6106 (Discontinued)
Inactive Ingredients: magnesium stearate, microcrystalline cellulose, sodium starch glycolate type A potato, titanium dioxide
Note: Inactive ingredients may vary.